NIH-funded research NIH-funded research

Effects of T cell therapy on COVID-19 immunity after bone marrow transplant

Official title: K23 Resubmission - Impact of adoptive T cell therapy on immunity to SARS-CoV-2 after bone marrow transplant

Funded at Children's Research Institute · NIH-10886377 · Data updated 2026-11-12

This study is looking at how a special treatment using immune cells from donors can help protect children who have had bone marrow transplants from getting COVID-19, and it aims to find safe ways to make these cells even more effective while they are on medications that weaken their immune system.

More SARS-CoV-2 research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionChildren's Research Institute
NIH-funded
Lab location1 site (Washington, United States)
Project startAugust 15, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$160,518
NIH project number1K23HL168161-01A1
Project IDNIH-10886377 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children who have recently undergone hematopoietic stem cell transplants and are at risk for SARS-CoV-2 infection.

Less likely to help

Patients who are not post-bone marrow transplant or those who are not at risk for COVID-19 may not benefit from this research.

What this research studies

This research investigates how adoptive T cell therapy can enhance the immune response to SARS-CoV-2 in children who have undergone bone marrow transplants. The study aims to assess the safety and effectiveness of using donor-derived T cells specifically targeting the virus to prevent infection in these vulnerable patients. By conducting a clinical trial, researchers will also explore ways to genetically modify these T cells to maintain their antiviral properties even when patients are treated with certain immunosuppressive medications. This approach could provide critical insights into improving post-transplant care for children.

Why it matters

Potential benefit: If successful, this research could significantly improve the ability of children post-bone marrow transplant to fight off COVID-19 infections.

How similar studies have gone: Previous research has shown promise in using T cell therapies for viral infections, suggesting potential success for this novel approach.

Where this research is happening

  • Children's Research Institute
    Washington, United States
    Active

Researchers

  • Principal investigator: Conway, Susan — Children's Research Institute
  • Study coordinator: Conway, Susan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.